Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

FIRST SOLAR, INC. (FSLR)

As of 2026-11-08 · 13/15 boxes filled from SEC filings and market data

Conclusion: SHORT

Conviction medium · base case -52% · downside -82% · upside -1%

The market is capitalizing TTM EBITDA of $2.48B at 8.1x, but that EBITDA is 2.2x the FY2020-FY2025 cycle average of $1.12B; at the same 8.1x multiple, normalized EBITDA supports about $97/share, -52%. The 2026-10-29 guidance cut and the backlog slide from 47.9 GW to 44.0 GW are the catalysts that can force the market to re-base on cycle earnings, while the $500M buyback and Section 232 pricing are the main supports. The stock is a short: base -52%, downside -82%, upside only -1% at today's multiple, so the asymmetry is against a buyer. Conviction is medium because peak margins could persist longer than the cycle base assumes and the 10.8% short interest can squeeze.

Key numbers

  • Share price: $201.14
  • Market cap: $21.62B
  • Latest financial period: TTM to Sep 30, 2026
  • Revenue (TTM): $5.01B
  • EV / EBITDA (TTM): 8.1x
  • P/E (TTM): 11.6x
  • Price / book: 1.99x

The 15 boxes

  1. ✓ 1. Long-form business notes

    First Solar's latest 10-K describes a CdTe module manufacturing and sales business concentrated in the U.S. (96% of 2025 net sales), while the FY2020 10-K still included power plant solutions, O&M and a U.S. project-development sale. Between FY2020 and FY2025 revenue went from $2.71B to $5.22B, with FY2022 the weak year (operating loss $27.2M) and FY2025 operating income $1.60B. Manufacturing has expanded from the older U.S./Malaysia/Vietnam footprint to include India and new U.S. Series 7 lines.

  2. ✓ 2. Competitive advantage

    The advantage is a technology and policy arbitrage, not a pricing moat: First Solar competes on sales price per watt against crystalline silicon makers, the majority linked to China, and the 10-K concedes those rivals may have sovereign capital and can run at minimal or negative operating margins for sustained periods. What the company does claim is differentiated thin-film (CdTe, no polysilicon) technology, integrated manufacturing and a tightly controlled supply chain - and U.S. domestic-content/FEOC and Indian local-content rules that change relative cost positions. The financial record supports scale economics but not stability: gross margin ran 25.1% (FY2020), 25.0% (FY2021), 2.7% (FY2022), 39.2% (FY2023), 44.2% (FY2024), 40.6% (FY2025), with operating margin at -1.0% in FY2022 - a five-year step-up that one demand-air-pocket year erased. A $50 million warranty liability at 12/31/2025 for identified manufacturing issues is a direct offset to the quality/reliability leg of the pitch.

  3. ✓ 3. 10-Q takeaways

    Q3 2026 net sales fell 22.8% y/y to $1.2B on lower third-party module volume and contract terminations, while gross margin rose to 57.9% from 38.3% on more Section 45X-qualifying modules and higher ASP; net income was $571M ($5.30 diluted) and Adjusted EBITDA $744M. Net cash was $1.5B at Sep 30 2026 vs $2.4B at Dec 31 2025, inventories rose to $1,138.584M, and the board authorized a $500M buyback. 2026 guidance was cut for volume and net sales but gross profit was unchanged; backlog was 44.0 GW/$13.5B. The 10-Q risk-factor update says no material changes except the listed subsidy/tariff risk, and MD&A flags the Section 232 polysilicon proclamation effective Dec 4 2026.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ✓ 9. Insider trading interpretation

    Filled; members read this box.

  10. ○ 10. Earnings-call notes
  11. ✓ 11. Impression of the shareholder letter

    Filled; members read this box.

  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans